Skip to content

Sodium Bicarbonate for Prevention of Contrast-Induced Nephropathy in Diabetic Patients with Renal Insufficiency

Sodium Bicarbonate for Prevention of Contrast-Induced Nephropathy in Diabetic Patients with Renal Insufficiency

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2007-007546-36-CZ
Enrollment
Unknown
Registered
2008-01-24
Start date
2008-03-20
Completion date
Unknown
Last updated
2013-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus with renal insufficiency MedDRA version: 9.1 Level: LLT Classification code 10012601 Term: Diabetes mellitus MedDRA version: 9.1 Level: LLT Classification code 10038474 Term: Renal insufficiency

Interventions

Trade Name: Ardeaelytosol conc. natriumhydrogenkarbonát 4,2% (8,4%) Product Name: Sodium bicarbonate Product Code: NaHCO3 Pharmaceutical Form: Solution for infusion Other descriptive name: SODIUM BICA

Sponsors

Institute for Clinical and Experimental Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Scheduled procedure with exposure to radiographic contrast Age = 18 years Diabetes mellitus defined by use of antidiabetic medication Stable renal insufficiency with P-creatinine = 100 µmol/l Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Emergency procedure P-creatinine = 500 µmol/l or dialysis treatment Acute renal failure with P-creatinine change of = 50 µmol/l / 24 hours Fluid overload with pulmonary edema Uncontrolled hypertension (systolic BP = 180 and/or diastolic BP = 110 mmHg) or hemodynamic instability (systolic BP = 90 and/or diastolic BP = 50 mmHg) Allergy to or use of radiographic contrast within 2 days of the study Use of other treatment to prevent contrast-induced nephropathy Multiple myeloma Pregnancy Planned use of other medical substance to prevent radiocontrast nephropathy

Design outcomes

Primary

MeasureTime frame
Main Objective: To assess the efficacy of sodium bicarbonate versus sodium chloride infusion for the prevention of contrast-induced nephropathy (defined as maximum change in plasma creatinine = 25%, or = 44,2 µmol/l on postcontrast days 1 and 2) in diabetic patients with renal insufficiency undergoing procedures with exposure to radiographic contrast ;Secondary Objective: To asess the effect of sodium bicarbonate versus sodium chloride infusion on the maximum change in plasma creatinine and estimated glomerular filtration rate (MDRD equation) in diabetic patients with renal insufficiency undergoing procedures with exposure to radiographic contrast ;Primary end point(s): Maximal change in P-creatinine within postcontrast days 1 and 2 versus precontrast level

Countries

Czech Republic

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026